Viewing Study NCT00055757


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2025-12-28 @ 11:23 AM
Study NCT ID: NCT00055757
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module